Those injunctions relate to potential labelling and warnings relating to the products. In a statement, Johnson & Johnson's head of communications in Australia said: "Ethicon empathises with those women who have experienced complications following pelvic organ prolapse and stress urinary incontinence surgical procedures." Ethicon believed it "acted ethically and responsibly in the research, development and supply of these products" and said "pelvic mesh has helped improve the quality of life for millions of women with pelvic organ prolapse and stress urinary incontinence, which are serious, debilitating conditions that can cause daily suffering".